Market Research Reports and Industry Reports

US Healthcare Advertising: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2021

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Health related issues are growing rapidly all over the world making healthcare a major issue of concern. Health problems are fuelled by poverty, aging population and obesity in both developed and developing societies. As the economies grow and global disposable incomes rise, individuals demand better care and advanced medical interventions. Thus, the pace of growth in global health care spending, particularly in developing nations, is expected to accelerate rapidly for the foreseeable future. The healthcare spending in the United States is far greater than other countries. Currently, the United States has one of the highest per capita expenditure on healthcare with estimates suggesting that by 2020 the US will spend approximately 28% of its GDP on healthcare.
The increasing value that people place on social media and advertisements has brought about the integration of marketing and healthcare in the recent past. Healthcare corporations are increasing their expenditure on advertising through various channels like, television, print ads, social media, detailing, etc. and there is a shift of healthcare brands putting more money into the digital space.
The key healthcare segments analysed in this report are the Pharmaceutical (small molecule drugs) Market, Biopharmaceutical Market, Vaccines Market and Over-the-Counter (OTC) Drugs Market in the United States. For each of the healthcare segments, the report provides the share of various advertising channels such as detailing, sampling, Direct-to-Consumer (DTC), mailing/e-mailing, print advertising, etc. The report finds that detailing represents the most preferred mode of promotion across all the healthcare segments.
The healthcare market in the United States comprises of major players like Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche, among many others. All these pharmaceutical corporations spend a large amount of their earnings on promotions and advertising of their drugs and healthcare products.
IMARCs new report US Healthcare Advertising: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2021 provides an analytical and statistical insight into the advertising trends in the healthcare sector in the United States. The market analysis includes market trends, key players in the healthcare sector, sales and advertising trends in the different sectors, breakup by advertising channels, etc. The study, which is based both on desk research and multiple waves of qualitative primary research, is a must-read for entrepreneurs, investors, researchers, consultants, business strategists and all those who are planning to foray into US healthcare advertising market in any manner.

Key Questions Answered in this Report:
How is healthcare advertising different from conventional advertising?
What are the different channels for healthcare advertising?
What drives the healthcare advertising market in the US?
What is the value chain of the healthcare advertising market in the US?
What are the current trends in the US healthcare advertising industry?
What are the historical, current and future trends of the advertising spend on healthcare sector in the US?
What are the historical, current and future sales value trends and advertising spend of the pharmaceutical (small molecule drugs) market in the healthcare sector in the US?
What are the historical, current and future sales value trends and advertising spend of the biopharmaceutical market in the US?
What are the historical, current and future sales value trends and advertising spend of the vaccines market in the US?
What are the historical, current and future sales value trends and advertising spend of the Over-the-Counter (OTC) drugs market in the US?
What is the breakup of the key advertising channels of the pharmaceutical market in the US?
What is the breakup of the key advertising channels of the biopharmaceutical market in the US?
What is the breakup of the key advertising channels of the vaccines market in the US?
What is the breakup of the key advertising channels of the Over-the-Counter (OTC) drugs market in the US?
Who are the key players in the pharmaceutical market, biopharmaceutical market, vaccines market and Over-the-Counter (OTC) drugs market in the US and what is their advertising spend?
Who are the key players in the US healthcare advertising market and what are the trends of their sales and advertising spend?
What are the challenges of the healthcare advertising market in the US?
1 Research Methodology and Market Definitions
2 Executive Summary
3 An Overview of Healthcare Advertising in the United States
4 What Drives the Healthcare Advertising Market in the United States?
4.1 Digitalization and other Technological Advancements
4.2 Increasing Presence of Generic and Me-too Drugs
4.3 Government Regulations Supporting DTC Advertising
4.4 Launch of New Drugs
4.5 Increased Consumer Reach through Mobile Advertising
4.6 Other Key Drivers
5 Healthcare Advertising Market: Value Chain
5.1 DTC Advertising
5.2 Detailing
6 Current Trends in Healthcare Advertising
6.1 Focus on Content
6.2 Rise of Multichannel Marketing
6.3 Targeting Consumers with Local Advertising
6.4 Reliance on Social Media
6.5 Surging Mobile Marketing
6.6 Consumers Becoming Researchers
6.7 Information Dispensed through Videos
6.8 Increasing Importance of Online Reviews
7 US Healthcare Advertising Market: SWOT Analysis
7.1 Strength
7.2 Weakness
7.3 Opportunities
7.4 Threats
8 US Healthcare Advertising market: Porters Five Forces Analysis
8.1 Overview
8.2 Bargaining Power of Buyers
8.3 Bargaining Power of Suppliers
8.4 Degree of Competition
8.5 Threat of New Entrants
8.6 Threat of Substitutes
9 US Healthcare Advertising Market
9.1 Historical and Current Market Trends
9.2 Market Segmentation by Product Type
9.2.1 Pharmaceutical (Small Molecule Drugs) Advertising Market
9.2.1.1 Historical, Current and Future Trends in the Pharmaceutical
(Small Molecule Drugs) Market
9.2.1.2 Historical, Current and Future Trends in the Pharmaceutical
(Small Molecule) Advertising Market
9.2.1.3 Market Breakup by Advertising Channel
9.2.1.4 Advertising Spend by Key Players
9.2.2 Biopharmaceutical Market
9.2.2.1 Historical, Current and Future Market Trends in the
Biopharmaceutical Market
9.2.2.2 Historical, Current and Future Market Trends in the
Biopharmaceutical Advertising Market
9.2.2.3 Market Breakup by Advertising Channel
9.2.2.4 Advertising spend by Key Players
9.2.3 Vaccines Market
9.2.3.1 Historical, Current and Future Market Trends in the
Vaccines Market
9.2.3.2 Historical, Current and Future Market Trends in the Vaccines Advertising Market
9.2.3.3 Market Breakup by Advertising Channel
9.2.3.4 Advertising Spend by Key Players
9.2.4 Over-the-Counter Drugs Market
9.2.4.1 Historical, Current and Future Market Trends in the OTC Drugs Market
9.2.4.2 Historical, Current and Future Market Trends in the OTC Drugs Advertising Market
9.2.4.3 Market Breakup by Channel
9.2.4.4 Advertising Spend by Key Players
10 Major Players: Sales and Advertising Spend
10.1 Advertising Spend by Major Pharma Companies
10.1.1 Johnson & Johnson
10.1.1.1 US Sales
10.1.1.2 Advertising Spend by Channel
10.1.1.3 Global Sales and Advertising Spend
10.1.2 Pfizer
10.1.2.1 US Sales
10.1.2.2 Advertising Spend by Channel
10.1.2.3 Global Sales and Advertising Spend
10.1.3 Merck & Co.
10.1.3.1 US Sales
10.1.3.2 Advertising Spend by Channel
10.1.3.3 Global Sales and Advertising Spend
10.1.4 GlaxoSmithKline
10.1.4.1 US Sales
10.1.4.2 Advertising Spend By Channel
10.1.4.3 Global Sales and Advertising Spend
10.1.5 Eli Lilly
10.1.5.1 US Sales
10.1.5.2 Advertising Spend by Channel
10.1.5.3 Global Sales and Advertising Spend
10.1.6 Novartis
10.1.6.1 US Sales
10.1.6.2 Total Sales of Different Segments
10.1.6.3 Advertising Spend by Channel
10.1.6.4 Global Sales and Advertising Spend
10.1.7 Sanofi
10.1.7.1 US Sales
10.1.7.2 Advertising Spend on Different Segments
10.1.7.3 Global Sales and Advertising Spend
10.1.8 AstraZeneca
10.1.8.1 US Sales
10.1.8.2 Advertising Spend by Channel
10.1.8.3 Global Sales and Advertising Spend
10.1.9 Roche
10.1.9.1 US Sales
10.1.9.2 Advertising Spend on Different Segments
10.1.9.3 Global Sales and Advertising Spend
10.1.10 Bayer HealthCare
10.1.10.1 US Sales
10.1.10.2 Advertising Spend on Different Segments
10.1.10.3 Global Sales and Advertising Spend
10.1.11 Bristol- Myers Squibb
10.1.11.1 US Sales
10.1.11.2 Advertising Spend by Channel
10.1.11.3 Global Sales and Advertising Spend
11 Market Challenges
11.1 Trust Gap between Consumers and Advertisers
11.2 Strict Rules and Regulations by FDA
11.3 Unethical Practices
11.4 Macroeconomic Scenario
11.5 Other Challenges

List Of Tables

Table 1: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend by Key Players, 2015
Table 2: US: Biopharmaceutical Market: Advertising Spend by Key Players, 2015
Table 3: US: Vaccines Market: Advertising Spend by Key Players, 2015
Table 4: US: OTC Drugs Market: Advertising Spend by Key Players, 2015
Table 5: US: Advertising Spend by Major Players, (in USD Million), 2015
Table 6: Pfizer: Advertising Spend on Different Channels (in USD Million), 2012
Table 7: Merck & Co: Advertising Spend on Different Channels (in USD Million), 2015
Table 8: GSK: Advertising Spend on Different Channels (in USD Million), 2012
Table 9: Eli Lilly: Advertising Spend on Different Channels (in USD Million), 2012
Table 10: Novartis: Total Sales of Different Segments (in USD Million), 2013-2015
Table 11: Sanofi: Advertising Spend on Different Products (in USD Million), 2015
Table 12: AstraZeneca: Advertising Spend on Different Channels in the US (in USD Million), 2012
Table 13: Roche: Total Spending on Different Divisions (in USD Million), 2014

List Of Figures

Figure 1: US: Breakup of Healthcare Market
Figure 2: US: Healthcare Industry Digital Ad Spending (in USD Billion), 2013-2019
Figure 3: US Healthcare Advertising Market: SWOT Analysis
Figure 4: US Healthcare Advertising Market: Porters Five Forces Analysis
Figure 5: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2009-2016
Figure 6: US: Pharmaceuticals (Small Molecule Drugs): Sales Forecast (in USD Billion), 2017-2021
Figure 7: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2009-2016
Figure 8: US: Pharmaceutical (Small Molecule Drugs) Market: Sales Forecast (in USD Billion), 2017-2021
Figure 9: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend (in USD Billion), 2009-2016
Figure 10: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend Forecast (in USD Billion), 2017-2021
Figure 11: US: Pharmaceutical (Small Molecule Drugs) Market Advertising Spend: Breakup by Channels (in USD Billion), 2009-2016
Figure 12: US: Biopharmaceutical Market: Sales (in USD Billion), 2009-2016
Figure 13: US: Biopharmaceutical Market: Sales Forecast (in USD Billion), 2017-2021
Figure 14: US: Biopharmaceutical Market: Advertising Spend (in USD Billion), 2009-2016
Figure 15: US: Biopharmaceutical Market: Advertising Spending Forecast (in US$ Billion), 2015-2020
Figure 16: US: Biopharmaceutical Market: Advertising Spend: Breakup by Channels (in %), 2016
Figure 17: US: Biopharmaceutical Market: Advertising Spend Breakup by Different Providers (in %), 2016
Figure 18: US: Vaccines Market: Sales (in USD Billion), 2009-2016
Figure 19: US: Vaccines Market: Sales Forecast (in USD Billion), 2017-2021
Figure 20: US: Vaccines Market: Advertising Spend (in USD Billion), 2009-2016
Figure 21: US: Vaccines Market: Advertising Spend (in USD Billion), 2017-2021
Figure 22: US: OTC Drugs Market: Sales (in USD Billion), 2009-2016
Figure 23: US: OTC Drugs Market: Sales Forecast (in USD Billion), 2017-2021
Figure 24: US: OTC Drugs Market: Advertising Spend (in USD Billion), 2009-2016
Figure 25: US: OTC Drugs Market: Advertising Spend Forecast (in USD Billion), 2017-2021
Figure 26: US: OTC Drugs Market: Advertising Spend: Breakup by Channels (in %), 2016
Figure 27: US: Advertising Spend by Top Companies Breakup (in %), 2016
Figure 28: US: Pharmaceutical Marketing: Expenditure Breakup by Type (in %), 2016
Figure 29: Johnson & Johnson: US and Rest of the World Sales (in USD Billion), 2013-2015
Figure 30: Johnson & Johnson: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 31: Johnson & Johnson: Global Sales and Advertising Spend (in USD Billion), 2013-2015
Figure 32: Pfizer: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 33: Pfizer: Advertising Spend: Breakup by Different Channels in USA (in %), 2012
Figure 34: Pfizer: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 35: Merck & Co: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 36: Merck & Co: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 37: Merck & Co: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 38: GSK: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 39: GSK: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 40: GSK: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 41: Eli Lilly: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 42: Eli Lilly: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 43: Eli Lilly: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 44: Novartis: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 45: Novartis: Advertising Spend on Different Channels (in %), 2014
Figure 46: Novartis: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 47: Sanofi: US and Rest of the World sales (in USD Million), 2013-2015
Figure 48: Sanofi: Breakup of Spending on Different Products (in %), 2015
Figure 49: Sanofi: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 50: AstraZeneca: US and Rest of the World sales (in USD Million), 2013-2015
Figure 51: AstraZeneca: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 52: AstraZeneca: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 53: Roche: US and Rest of the World sales (in USD Million), 2013-2015
Figure 54: Roche: Breakup of Spending on Different Divisions (in %), 2014
Figure 55: Roche: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 56: Bayer Healthcare: US and Rest of the World sales (in USD Million), 2013-2015
Figure 57: Bayer & Healthcare: Breakup of Spending on Different Channels (in %), 2015
Figure 58: Bayer Healthcare: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 59: Bristol-Myers Squibb: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 60: Bristol-Myers Squibb: Breakup of Spending on Different Channels (in %), 2014
Figure 61: Bristol-Myers Squibb: Global Sales and Advertising Spend (in USD Million), 2013-2015

Balfour – 2830 South Main Street Senior Housing Complex – Michigan Project Profile

Synopsis Balfour 2830 South Main Street Senior Housing Complex Michigan Project Profile contains information on the scope of the project including project overview and location. The profile also details

USD 75View Report

MGNDC – Nashville Criminal Justice Center Development – Tennessee Project Profile

Synopsis MGNDC Nashville Criminal Justice Center Development Tennessee Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership

USD 75View Report

OBO – Tegucigalpa New US Embassy Development – Francisco Morazan Project Profile

Synopsis OBO Tegucigalpa New US Embassy Development Francisco Morazan Project Profile contains information on the scope of the project including project overview and location. The profile also details project

USD 75View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 1999
  • Hard copy    $ 2299
  • CD    $ 2299
  • Site Licence    $ 2699
  • Enterprise Wide Licence    $ 2699
$ 1999

Reports Details

Published Date : Apr 2017
No. of Pages :60
Country :United States of America
Category :Technology
Publisher :IMARC Group
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop
bostancı escort pendik escort kurtköy escort etiler escort şirinevler escort ankara escort ankara escort bayan escort ankara beylikdüzü escort avcılar escort ankara escort bayan